医学信息2019，Vol.32Issue(16)：127-128,2.DOI:10.3969/j.issn.1006-1959.2019.16.041
托伐普坦治疗AMI合并心力衰竭的疗效及对患者血清hs-CRP、NT-proBNP表达的影响
Efficacy of Tolvaptan in the Treatment of AMI Complicated with Heart Failure and its Effect on Serum hs-CRP and NT-proBNP Expression
纪东华1
作者信息
- 1. 佳木斯市中心医院心内科,黑龙江佳木斯154002
- 折叠
摘要
关键词
急性心肌梗死/心力衰竭/托伐普坦/hs-CRP/NT-proBNP分类
医药卫生引用本文复制引用
纪东华..托伐普坦治疗AMI合并心力衰竭的疗效及对患者血清hs-CRP、NT-proBNP表达的影响[J].医学信息,2019,32(16):127-128,2.
